Castle biosciences presents new data demonstrating the ability of decisiondx®-scc to identify tumors likely to metastasize in patients with cutaneous squamous cell carcinoma deemed low risk by traditional staging

Friendswood, texas--(business wire)---- $cstl #cstl--castle announced new data showing the ability of decisiondx-scc to identify cscc tumors likely to metastasize in patients deemed low risk by staging.
CSTL Ratings Summary
CSTL Quant Ranking